The FDA Just Approved Juvéderm Volux Filler for the Jawline. Here’s What You Need to Know
Video chats have become an integral part of most of our lives, and with the proliferation of TikTok makeup tutorials, many of us have tried some variation of contouring or highlighting makeup techniques to create shadow and light to enhance our features. These phenomena have drawn our attention to the aesthetic importance of a lesser-discussed facial feature: the jawline.
In recent years, demand has increased not just for cheek and lip contouring with dermal filler, but also for long-lasting jawline enhancement. It’s common for injectors to pair jawline and chin enhancement with cheek or lip enhancement, for example, to give the face a customized, structured look and an overall more youthful appearance. Now, a new filler promises to offer even more precision and cohesion in the jaw area: Juvéderm VOLUX™ XC.
Juvéderm Volux is the first hyaluronic acid-based dermal filler that is FDA-approved specifically for injection in the jawline area; it is also approved for use in the chin.
What is Juvéderm Volux, and how is it used?
Juvéderm Volux is the first hyaluronic acid-based dermal filler that is FDA-approved specifically for injection in the jawline area; it is also approved for use in the chin.
When injected beneath the skin, hyaluronic acid-based fillers remain in place up to 2 years to reverse volume loss, fill and lift lines and creases, and augment certain features for a more youthful appearance. Each filler is specifically formulated to be injected at a certain depth and location. Volux, in specific, is highly cohesive and structured in texture to allow your injector to create a chiseled, defined jawline with injections that precisely “lift” the skin through deep injections. Volux is ideal for this area due to its thick, less water-like texture when compared with other softer and more flexible products like Juvéderm Volbella (for lips) or even Juvéderm Voluma (for cheeks and chin).
Volux is thought to last a year or longer in most patients. In a clinical study, the manufacturer found that most patients were still happy with the effects of Volux injection 12 months after their treatment, though the duration of each individual’s filler can vary.
While Volux is now fully FDA-approved for use, Juvéderm’s newest addition to its filler collection is not expected to be widely available in the United States until early 2023. According to the manufacturer, training in the use of this product will begin this fall.
While Volux is now fully FDA-approved for use, Juvéderm’s newest addition to its filler collection is not expected to be widely available in the United States until early 2023.
What is the difference between Juvéderm Volux and Voluma?
Volux is a slightly more cohesive and thicker formula than Voluma. Both fillers build volume and create a lift beneath the skin, but while Voluma is FDA-approved for the chin and cheeks, Volux is FDA-approved to treat the chin and jawline.
Currently, formulas like Voluma are used “off label” (outside of their FDA-approved areas) to enhance and augment the jawline. When it becomes available in spring 2023, Volux will offer an even more highly structured formula that is ideal for creating a chiseled jawline appearance.
About Anderson Sobel Cosmetic Surgery
Triple board certified cosmetic surgeon Dr. Alexander Sobel offers a full range of non-surgical enhancements and cosmetic procedures for the face, breast, and body at Anderson Sobel Cosmetic Surgery. If you are in the Bellevue or Seattle area, you may schedule a consultation with Dr. Sobel today by calling 425.453.9060 or contacting our practice online.